| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |